naveenspark
naveenspark on Hacker News
Founders should invest time and effort to ask for more board seats. The YC doc is a good start but if you follow this to the letter you may lose control in your B or C when the B and C investor also want board seats. Also it’s important to keep in mind that there is no “standard.” Everything is always negotiable.
You could always try the startup for 1 year and see how it goes. This way you get past your cliff, and you will have a much better idea of whether or not it has a chance of becoming something. If its flopping around like a fish then you can always go to a big co. Yes it would have cost you some $$$ short term, but you would have probably learned a lot more simply by having to wear more hats. Plus its a lot of fun to build something new from the ground up.
Its unclear what Peter Thiel is supporting with this donation. This candidate is highly inconsistent. Perhaps his bet is that if this candidate is elected, it will result in chaos. A sharp, rapid upheaval will enable him to accelerate his overall agenda. Given his net worth he is insulated from the negative effects this chaos will have on everyone else. Given his net worth he, and others who support his agenda can quickly capitalize.
Great point. Editing my post to include this.
Offering to cover defense increases their overall cost. If they agree to provide defense up front prior to anyone filing, and they are able to file first, they are able to make the bet that the opposing party won't file a counter. If the opposing party has already filed, they cannot make that bet, and as a result they are less likely to cover defense in the contingency agreement.
From personal experience, the moment someone does
any work on a project they have a claim. The state of CA is extremely worker friendly in this regard. I've made this stupid mistake twice in two different startups unrelated to Immunity Project. The first time, we had someone interview for a job and attend a few meetings. We ended up not offering them the job and they filed a complaint. We fought it and ended up spending nearly six figures on legal + more then you can possibly imagine to settle. It know this sounds insane, but its true.
The second circumstance was a co-founder who stole cash from the company and was booted. Similar end result. In both cases we had no documentation (classic startup excuse), and strongly believed in the premise that if you didn't do the work, you don't deserve to be paid. We lost in both cases. One of the primary drivers in both cases was the dreaded contingency attorney. Anytime someone is able to get an attorney to take a case on contingency with minimal out of pocket cost, they have little reason to be reasonable. And because filing is the nuclear option in the first place, they don't care about fallout. Contingency attorneys are paid a % of the resulting settlement so they will drive the case as hard as needed to extract the maximum outcome. In some cases the attorney will manipulate their client in pursuit of this outcome even if its not in their clients best interest long term. It was smart for Kyle to file first because it makes it harder for the other party to retain a contingency attorney who will cover defense in the deal. This will dramatically increase the other parties cost to litigate the case.
Lessons learned:
1. ALWAYS put stuff in writing.
2. NEVER have anyone do any "work" without some written agreement on compensation.
3. The only winners in litigation are the lawyers.
4. 3pt14159 makes a great point: ALWAYS settle early. The longer you let something drag, the more it will cost. Its always best to try to settle prior to either party filing a lawsuit. In this case it sounds like Kyle tried to settle first but was unsuccessful.
David and Chris are extraordinary entrepreneurs. I learned a lot watching them build Zesty week over week during YC W14. This is a hard business to build. Providing consistent service in terms of restaurant relations, food quality, and delivery is non trivial. Zesty is the best at it. All of thedogeye's points about the value of serving high quality meals to your team are spot on. Congrats David, Chris and the Zesty crew!
Taylor Swift is signed to Big Machine Records (BMLG). Big Machine Records is distributed by Universal Music Group (UMG). I am sure BMLG/UMG received a sizable advance from Apple in exchange for streaming rights for their master recordings. UMG probably negotiated an even higher advance in exchange for permission to launch the 3 month free campaign. UMG / BMLG should be sharing this advance payment with their artists. Taylor knows this so a good question to ask is: What % of the advance is Taylor receiving? The answer is probably none because most artists receive nothing from these advance payments. Even the hugely successful ones. So why is Taylor writing this letter? She is extremely smart and has a brilliant team of advisors around her so she knows about the advance that Apple already paid UMG. While posting this letter fits into the general discourse regarding underpayments to artists from streaming services, behind the scenes she is likely negotiating her own, separate, significant advance from Apple. I would do the same if I were her.
Posted by
naveenspark on Thursday March 05, 2015 @01:22PM
from the playkeys.io dept.
Posted by
naveenspark on Monday June 16, 2014 @08:40PM
from the immunityproject.org dept.
I live and work in Oakland. My office is 3 blocks from 19th street BART in the heart of uptown. There is so much incredible development happening in this part of the city. The Hive project launches later this year (The Hub is already open in the space) with awesome new apartments, and amazing new food options. From Lake Merritt to Jack London Sq. to Rockridge to Montclair there are a wide range of options to consider for office / living space. Its also typically ~10 degrees warmer then SF. If you have any questions feel free to ask and I'll answer when I get back this afternoon.
The base compensation is reasonable given the high cost of living in SF and the personal risk associated with the job. The pension is tougher to justify. Up to 90% of your salary at age 58 until EOL is likely unsustainable for the city. Cue epic battle between those who support public pensions and those who don't.
Not sure why this is ruffling so many feathers. There are thousands of great tech companys to work for that aren't on any Google, Apple or EBay "no-hire" list and vice versa. I fail to see how a few big companys agreeing not to poach talent from each other artificially reduces the total compensation ceiling industry wide.
Disclosure: I am biased (Noora is in our YC batch). That being said, what Noora is doing is very important. If patients and caregivers have better education on what to do post treatment, outcomes improve. The cost savings gained from the reduction in readmissions is an added bonus. Go Edith and Katy!
Apologies if my post felt unnecessarily snarky. Yes I am cofounder @ Immunity Project, but I previously helped create Redbox Tickets so I have that hat on for this thread. My opinion on the video aside, when you have a line of people in front of you trying to get into an event, how does this help build community? You have such little time with each person because your #1 focus is getting them in the building. Even if its a small event you want people spending more time in the event not chatting with the ticket taker. What is the roadmap like for this feature? Perhaps that will help me better understand the value prop.
This feels gimmicky. How does this help solve real issues with admission control? The idea of admitting based on a face vs. a barcode for a reserved show won't work. Assuming this is for GA only? Why not just allow users to import photos from instagram, FB or similar? Are you going to make these photos available in bulk fashion to event organizers? I can see how this might be interesting for attendees to stalk who else was there but what is the value prop for event organizers? Would the event organizer get other info from the user such as email address? Why is this going to make me choose TicketLeap vs. TicketFly vs. TicketMob vs. Brown Paper vs. Eventbrite vs. anyone else in this insanely crowded industry? And for what its worth, the video is unnecessarily emotional. If I were you I would just cut to the chase on how this adds value to the ticketing ecosystem.
Congrats Sam! Thank you for the ridiculously good advice you give us and our fellow YC founders. The future is very bright for YC.
Hey this is Naveen from Immunity Project. We had a great experience w/ Crowdhoster. It performed well for us and Ajay + team were super responsive. Highly recommend it for those who are considering crowdfunding on their own domain.
We are using TrueVault for Immunity Project. We have some bias since TrueVault is in our YC batch, but Jason and Trey worked 24/7 to help us with our HIPAA compliance needs. They used their API to build a custom portal for us to securely communicate patient data over a weekend. We highly recommend them.
Thank you for the kind words and support! We are very focused on our stated goal which is ending HIV/AIDS with a free vaccine. We haven't received any pressure to stop our work yet. If we do we will definitely let you know so we can get your help in fighting back!
Naveen here from Immunity Project. Thanks for the question. We have not done receptor analysis. We are using animal models as our starting point - we are looking for an immune response with memory to the administered peptides - if we get that response in Phase I we should be in good shape!
We received the peptides from researchers who have a manuscript in publication and would like us to keep the sequences confidential until they publish. Please see below for similar statistical research looking for targets to beneficial regions on HIV:
Mothe B, Anuska L, Ibarrondo J, Daniels M, Miranda C, Zamarreno J, et al. Definition of the viral targets of protective HIV-1-specific T cell responses. Journal of Translational Medicine 2011;9(208):20.
re: your startup / cost savings on reagents, supplies and equipment, we would love to talk to you about that. Please email us at [email protected]. Thanks!
The article is describing one of the many explanations that has been brought forward to explain why controllers do what they do. If you are looking for a common denominator across controllers broadly, the selective epitope targeting explanation seems to make the most sense to us and does not appear to be constrained by anything but the individual's HLA type which essentially determines what epitopes a particular individual's immune system can "see."
More then happy to give you the full details on how we've set this up: the vaccine is being developed by Flow Pharma Inc. Instead of setting up our own 501(c)3, we setup a fiscal sponsorship agreement with Until There's A Cure, a leading HIV/AIDS focused 501(c)3. We are operating the project as a non profit even though our entity type is technically a corp. In other words we are obligated to follow 501(c)3 rules and regulations, and we are obligated to give our vaccine away for free regardless of our entity type. The primary reason we did this is because its much better to work with a well established 501(c)3 that has team members who can help provide validation and support then to start from scratch on your own. It is also much faster to do this then setup your own 501(c)3.
Right now the project is only relying epitopes derived from actual controller targets. Our hypothesis is that if we go after the epitopes that HIV controllers preferentially target that we will get an immune response with memory in humans just as we have so far in our animal studies. The only way to test this is to execute on our clinical trial in humans. The current experiment we are aiming to perform is a good middle ground since we will be immunizing human blood against HIV in a controlled environment and then testing that immunity.
Thank you for your support!
Yes our overhead is far lower. Our other "trick" is that several members of our team are multi-talented. For example Dr. Herst can do tissue culture work, formulation development, analytical chemistry, and immunochemistry.
HIV/AIDS is a giant problem. North of 35MM people are living with HIV worldwide and more are infected every day. Yes we have made strides in reducing infection rates, but we are far from solving this problem with existing approaches. To put this in context, nearly 5,000 people a day die from AIDS. That is like 10 747s falling out of the sky every single day. The only solution is a vaccine which is why we are doing what we are doing. There are many big problems for us to solve on our planet. HIV/AIDS is one of the biggest and hardest to solve.
Thank you for your support! Yes it will be presented as a double blind, placebo controlled study. Regarding the risky behavior point, this is a well known challenge with all vaccine studies. And yes telling people that they don't know whether or not they have the actual vaccine helps in mitigating the risk effect.
We are pursuing all major funders we know of for funding for our work (including Bill and Melinda Gates Foundation etc.). The challenge is that it takes significant time to prepare grants apps, and go through the process. Some large funders such as EJAF only accept grant applications once a year. HIV/AIDS is an urgent challenge. Therefore we are crowd funding these dollars now to move our project forward immediately. In terms of the PRJ question, the bottom line is its a chicken and egg problem. Its harder to get published if you release all of the data prior to publication. Post publication, our goal is to make our project as open access as humanely possible. All of that being said, we do have more information about our work on our site:
http://www.immunityproject.org. If you have specific questions about our approach please feel free to ask them.